Insider Transactions in Q4 2025 at Maze Therapeutics, Inc. (MAZE)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2025
|
Amy Bachrodt SVP, Finance |
SELL
Open market or private sale
|
Direct |
5,000
-27.83%
|
$200,000
$40.08 P/Share
|
|
Dec 30
2025
|
Amy Bachrodt SVP, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+13.08%
|
$50,000
$10.42 P/Share
|
|
Dec 30
2025
|
Atul Dandekar CSBO |
SELL
Open market or private sale
|
Direct |
100
-0.94%
|
$4,000
$40.36 P/Share
|
|
Dec 30
2025
|
Atul Dandekar CSBO |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.93%
|
$1,000
$10.42 P/Share
|
|
Dec 29
2025
|
Amy Bachrodt SVP, Finance |
SELL
Open market or private sale
|
Direct |
10,000
-22.68%
|
$400,000
$40.85 P/Share
|
|
Dec 29
2025
|
Amy Bachrodt SVP, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+15.51%
|
$100,000
$10.42 P/Share
|
|
Dec 29
2025
|
Harold Bernstein President, R&D & CMO |
SELL
Open market or private sale
|
Direct |
45,000
-80.89%
|
$1,800,000
$40.64 P/Share
|
|
Dec 29
2025
|
Harold Bernstein President, R&D & CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+50.0%
|
$450,000
$10.42 P/Share
|
|
Dec 29
2025
|
Atul Dandekar CSBO |
SELL
Open market or private sale
|
Direct |
72,400
-58.27%
|
$2,896,000
$40.82 P/Share
|
|
Dec 29
2025
|
Atul Dandekar CSBO |
BUY
Exercise of conversion of derivative security
|
Direct |
72,400
+46.62%
|
$724,000
$10.42 P/Share
|
|
Nov 19
2025
|
Charles J Homcy |
BUY
Other acquisition or disposition
|
Direct |
1,489
+4.57%
|
-
|
|
Nov 04
2025
|
Third Rock Ventures Iv, L.P. |
SELL
Other acquisition or disposition
|
Direct |
1,600,000
-26.34%
|
-
|
|
Oct 23
2025
|
Charles J Homcy |
SELL
Bona fide gift
|
Direct |
28,423
-48.97%
|
-
|